To treat or not to treat: A rare case of response to pembrolizumab‐based immunotherapy‐chemotherapy in non‐small cell lung cancer with acute liver failure due to multiple bile duct metastases-Reference-Cited by-同舟云学术

To treat or not to treat: A rare case of response to pembrolizumab‐based immunotherapy‐chemotherapy in non‐small cell lung cancer with acute liver failure due to multiple bile duct metastases

Published:2020-12-27 Issue:4 Volume:12 Page:553-556
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Shaforostova Inna¹^ORCID,Huss Sebastian²,Gerwing Mirjam³,Evers Georg¹,Bleckmann Annalen¹

Affiliation:

1. Department of Medicine A: Hematology, Hemostaseology, Oncology and Pneumology University Hospital Muenster Muenster Germany

2. Gerhard‐Domagk‐Institute of Pathology University Hospital Muenster Muenster Germany

3. Clinic of Radiology University Hospital Muenster Muenster Germany

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13793

Reference15 articles.

1. Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer: A National Cancer Database Survey

2. Specific organ metastases and survival in metastatic non-small-cell lung cancer

3. KEYNOTE‐042: Is lowering the PD‐L1 threshold for first‐line pembrolizumab monotherapy a good idea?;Pacheco JM;Transl Lung Cancer Res,2019

4. Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer

5. Role of Radiotherapy for Local Control of Asymptomatic Adrenal Metastasis From Lung Cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Successful treatment with nivolumab in a patient with gastric cancer with severe liver failure resulting from multiple liver metastases: A case report;Oncology Letters;2024-04-18

2. Insuffisance d’organe (cœur, rein, foie) et traitements du cancer pulmonaire;Revue des Maladies Respiratoires Actualités;2023-10

3. Immunotherapy Versus Hospice: Treatment Decision-Making in the Modern Era of Novel Cancer Therapies;Current Oncology Reports;2022-02-03